Pharmaceutical company Novo Nordisk is waiting on federal approval to sell its blockbuster GLP-1 weight-loss treatment as a pill.

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

President Donald Trump seen leaving the White House to play a round of golf on Easter Sunday. Scientists studied late sleepers for 8 years and this is what they found Anant Ambani, Radhika ...

The Rams benched White after a rocky start during which he allowed four touchdowns. L.A. then sent the cornerback and a seventh-round pick in the 2027 NFL Draft to the Baltimore Ravens for a ...